Abers, M. S., Delmonte, O. M., Ricotta, E. E., Fintzi, J., Fink, D. L., de Jesus, A. A. A., . . . Notarangelo, L. D. (2021). An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI insight, 6(1), . https://doi.org/10.1172/jci.insight.144455
Chicago Style (17th ed.) CitationAbers, Michael S., et al. "An Immune-based Biomarker Signature Is Associated with Mortality in COVID-19 Patients." JCI Insight 6, no. 1 (2021). https://doi.org/10.1172/jci.insight.144455.
MLA (9th ed.) CitationAbers, Michael S., et al. "An Immune-based Biomarker Signature Is Associated with Mortality in COVID-19 Patients." JCI Insight, vol. 6, no. 1, 2021, https://doi.org/10.1172/jci.insight.144455.
Warning: These citations may not always be 100% accurate.